Abbott Laboratories is raising its projected full-year 2022 diluted earnings per share under GAAP to at least $3.50.
Market Closed -
Other stock markets
|
Pre-market 08:26:36 am | |||
107.6 USD | +3.17% |
|
107.6 | +0.03% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.26% | 187B | |
+2.05% | 110B | |
-1.31% | 69.54B | |
+14.65% | 46.37B | |
-6.69% | 46.05B | |
+7.97% | 42.54B | |
+18.60% | 30.72B | |
+17.70% | 25.62B | |
-6.87% | 23.32B | |
-10.63% | 22.92B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Abbott Laboratories Raises Earnings Guidance for 2022